Decreased microglial activation in MS patients treated with glatiramer acetate

Journal of Neurology

Volumn 259, Issue 6, 2012, Pages 1199-1205

  Ratchford, John N ^a   Endres, Christopher J ^a   Hammoud, Dima A ^a   Pomper, Martin G ^a   Shiee, Navid ^a   McGready, John ^b   Pham, Dzung L ^c,d   Calabresi, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Johns Hopkins University   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Copolymer 1; Immunology; Microglia; Multiple sclerosis; PK11195; Positron emission tomography

Indexed keywords

GLATIRAMER; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; NATALIZUMAB;

ADULT; ARTICLE; BRAIN ATROPHY; CAUDATE NUCLEUS; CELL ACTIVATION; CLINICAL ARTICLE; CLINICAL EVALUATION; DISEASE DURATION; DRUG SUBSTITUTION; DRUG UPTAKE; FEMALE; GRAY MATTER; HUMAN; INFLAMMATION; MALE; MICROGLIAL ACTIVATION; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; THALAMUS; WHITE MATTER;

ADULT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MICROGLIA; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PEPTIDES; PROTEIN BINDING; TREATMENT OUTCOME;

EID: 84862764134     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-6337-x     Document Type: Article

References (33)

1. BD Trapp J Peterson RM Ransohoff R Rudick S Mork L Bo 1998 Axonal transection in the lesions of multiple sclerosis N Engl J Med 338 278 285 9445407 10.1056/NEJM199801293380502 1:STN:280:DyaK1c%2Fpt1SksA%3D%3D
2. VH Perry S Gordon 1991 Macrophages and the nervous system Int Rev Cytol 125 203 244 1851730 10.1016/S0074-7696(08)61220-6 1:STN:280:DyaK3M3js1egsQ%3D%3D
3. GJ Guillemin BJ Brew 2004 Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification J Leukoc Biol 75 388 397 14612429 10.1189/jlb.0303114 1:CAS:528:DC%2BD2cXis1ehsr0%3D
4. J Gehrmann Y Matsumoto GW Kreutzberg 1995 Microglia: intrinsic immuneffector cell of the brain Brain Res Brain Res Rev 20 269 287 7550361 10.1016/0165-0173(94)00015-H 1:STN:280:DyaK28%2FjtFOmsA%3D%3D
5. F Dangond A Windhagen CJ Groves DA Hafler 1997 Constitutive expression of costimulatory molecules by human microglia and its relevance to CNS autoimmunity J Neuroimmunol 76 132 138 9184642 10.1016/S0165-5728(97)00043-X 1:CAS:528:DyaK2sXislentrw%3D
6. EN Benveniste 1997 Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis J Mol Med 75 165 173 9106073 10.1007/s001090050101 1:CAS:528:DyaK2sXisF2gt74%3D
7. J Bauer T Sminia FG Wouterlood CD Dijkstra 1994 Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis J Neurosci Res 38 365 375 7932870 10.1002/jnr.490380402 1:STN:280:DyaK2M%2FhvVeqsg%3D%3D
8. CF Brosnan MB Bornstein BR Bloom 1981 The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis J Immunol 126 614 620 6256443 1:STN:280:DyaL3M%2FpsFWgtg%3D%3D
9. I Huitinga N van Rooijen CJ de Groot BM Uitdehaag CD Dijkstra 1990 Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages J Exp Med 172 1025 1033 2145387 10.1084/jem.172.4. 1025 1:STN:280:DyaK3M%2FhtFansA%3D%3D
10. S Sriram M Rodriguez 1997 Indictment of the microglia as the villain in multiple sclerosis Neurology 48 464 470 9040740 10.1212/WNL.48.2.464 1:STN:280:DyaK2s7ptlWnug%3D%3D
11. A Dubois J Benavides B Peny D Duverger D Fage B Gotti ET MacKenzie B Scatton 1988 Imaging of primary and remote ischaemic and excitotoxic brain lesions. An autoradiographic study of peripheral type benzodiazepine binding sites in the rat and cat Brain Res 445 77 90 2835123 10.1016/0006-8993(88)91076- 1 1:CAS:528:DyaL1cXhvVCls7g%3D
12. R Myers LG Manjil BM Cullen GW Price RS Frackowiak JE Cremer 1991 Macrophage and astrocyte populations in relation to [3H]PK 11195 binding in rat cerebral cortex following a local ischaemic lesion J Cereb Blood Flow Metab 11 314 322 1997503 10.1038/jcbfm.1991.64 1:CAS:528:DyaK3MXktVKgtr8%3D
13. RB Banati R Myers GW Kreutzberg 1997 PK ('peripheral benzodiazepine')- binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK11195 binding to activated microglia J Neurocytol 26 77 82 9181482 10.1023/A:1018567510105 1:CAS:528:DyaK2sXktVSksrk%3D
14. RB Banati J Newcombe RN Gunn A Cagnin F Turkheimer F Heppner G Price F Wegner G Giovannoni DH Miller GD Perkin T Smith AK Hewson G Bydder GW Kreutzberg T Jones ML Cuzner R Myers 2000 The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity Brain 123 Pt 11 2321 2337 11050032 10.1093/brain/123.11.2321
15. P Casellas S Galiegue AS Basile 2002 Peripheral benzodiazepine receptors and mitochondrial function Neurochem Int 40 475 486 11850104 10.1016/S0197-0186(01)00118-8 1:CAS:528:DC%2BD38XhtFyktLs%3D
16. S Venneti BJ Lopresti CA Wiley 2006 The peripheral benzodiazepine receptor (Translocator protein 18 kDa) in microglia: from pathology to imaging Prog Neurobiol 80 308 322 17156911 10.1016/j.pneurobio.2006.10.002 1:CAS:528:DC%2BD2sXntlyhtg%3D%3D
17. JC Debruyne J Versijpt KJ Van Laere F De Vos J Keppens K Strijckmans E Achten G Slegers RA Dierckx J Korf JL De Reuck 2003 PET visualization of microglia in multiple sclerosis patients using [11C]PK11195 Eur J Neurol 10 257 264 12752399 10.1046/j.1468-1331.2003.00571.x 1:STN:280:DC%2BD3s3jvFygsA%3D%3D
18. J Versijpt JC Debruyne KJ Van Laere F De Vos J Keppens K Strijckmans E Achten G Slegers RA Dierckx J Korf JL De Reuck 2005 Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study Mult Scler 11 127 134 15794383 10.1191/1352458505ms1140oa 1:STN:280:DC%2BD2M7mt1Sqsw%3D%3D
19. M Politis P Giannetti P Su F Turkheimer S Keihaninejad K Wu A Waldman R Reynolds R Nicholas P Piccini 2010 Cortical microglial activation is associated with disability in secondary progressive multiple sclerosis: an in vivo imaging study Neurology 74 A290
20. U Oh M Fujita VN Ikonomidou IE Evangelou E Matsuura E Harberts J Ohayon VW Pike Y Zhang SS Zoghbi RB Innis S Jacobson 2010 Translocator Protein PET Imaging for Glial Activation in Multiple Sclerosis J Neuroimmune Pharmacol 6 354 361 20872081 10.1007/s11481-010-9243-6
21. CH Polman SC Reingold G Edan M Filippi HP Hartung L Kappos FD Lublin LM Metz HF McFarland PW O'Connor M Sandberg-Wollheim AJ Thompson BG Weinshenker JS Wolinsky 2005 Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria" Ann Neurol 58 840 846 16283615 10.1002/ana.20703
22. N Shiee PL Bazin A Ozturk DS Reich PA Calabresi DL Pham 2010 A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions Neuroimage 49 1524 1535 19766196 10.1016/j.neuroimage.2009.09. 005
23. MA Kropholler R Boellaard BN van Berckel A Schuitemaker RW Kloet MJ Lubberink C Jonker P Scheltens AA Lammertsma 2007 Evaluation of reference regions for (R)-[(11)C]PK11195 studies in Alzheimer's disease and mild cognitive impairment J Cereb Blood Flow Metab 27 1965 1974 17406654 10.1038/sj.jcbfm. 9600488 1:CAS:528:DC%2BD2sXhtlWqurvP
24. J Logan JS Fowler ND Volkow GJ Wang YS Ding DL Alexoff 1996 Distribution volume ratios without blood sampling from graphical analysis of PET data J Cereb Blood Flow Metab 16 834 840 8784228 10.1097/00004647-199609000-00008 1:STN:280:DyaK28znvVKltw%3D%3D
25. J Ashburner 2007 A fast diffeomorphic image registration algorithm Neuroimage 38 95 113 17761438 10.1016/j.neuroimage.2007.07.007
26. LJ Lawson VH Perry P Dri S Gordon 1990 Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain Neuroscience 39 151 170 2089275 10.1016/0306-4522(90)90229-W 1:STN:280:DyaK3M3htFyiuw%3D%3D
27. S Dhib-Jalbut 2002 Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis Neurology 58 S3 S9 11971121 10.1212/WNL.58.8- suppl-4.S3 1:CAS:528:DC%2BD38XjslSqsro%3D
28. HJ Kim I Ifergan JP Antel R Seguin M Duddy Y Lapierre F Jalili A Bar-Or 2004 Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis J Immunol 172 7144 7153 15153538 1:CAS:528:DC%2BD2cXktFSku7s%3D
29. R Pul D Moharregh-Khiabani J Skuljec T Skripuletz N Garde EV Voss M Stangel 2010 Glatiramer acetate modulates TNF-alpha and IL-10 secretion in microglia and promotes their phagocytic activity J Neuroimmune Pharmacol 6 381 388 21046275 10.1007/s11481-010-9248-1
30. BD Trapp JR Wujek GA Criste W Jalabi X Yin GJ Kidd S Stohlman R Ransohoff 2007 Evidence for synaptic stripping by cortical microglia Glia 55 360 368 17136771 10.1002/glia.20462
31. R Dutta J McDonough X Yin J Peterson A Chang T Torres T Gudz WB Macklin DA Lewis RJ Fox R Rudick K Mirnics BD Trapp 2006 Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients Ann Neurol 59 478 489 16392116 10.1002/ana.20736 1:CAS:528:DC%2BD28XjtV2ltr4%3D
32. CJ Endres MG Pomper M James O Uzuner DA Hammoud CC Watkins A Reynolds J Hilton RF Dannals M Kassiou 2009 Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans J Nucl Med 50 1276 1282 19617321 10.2967/jnumed.109. 062265 1:CAS:528:DC%2BD1MXhtVymtrrL
33. Y Ikoma F Yasuno H Ito T Suhara M Ota H Toyama Y Fujimura A Takano J Maeda MR Zhang R Nakao K Suzuki 2007 Quantitative analysis for estimating binding potential of the peripheral benzodiazepine receptor with [(11)C]DAA1106 J Cereb Blood Flow Metab 27 173 184 16685259 10.1038/sj.jcbfm.9600325 1:CAS:528:DC%2BD2sXptleqsg%3D%3D